id: hepatitis_c_prevalence_to_NEW:cirrhosis
name: Hepatitis C Prevalence â†’ Cirrhosis
from_node:
  node_id: hepatitis_c_prevalence
  node_name: Hepatitis C Prevalence
to_node:
  node_id: NEW:cirrhosis
  node_name: Cirrhosis
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Hepatitis C virus (HCV) establishes chronic infection in hepatocytes, leading
  to persistent viral replication and immune-mediated liver injury'
- 'Step 2: Chronic inflammation triggers hepatic stellate cell activation and progressive
  fibrogenesis with collagen deposition'
- 'Step 3: Sustained fibrosis over years to decades leads to architectural distortion,
  nodule formation, and eventual cirrhosis'
- 'Step 4: Cirrhosis manifests with portal hypertension and hepatic dysfunction, leading
  to complications including ascites, hepatic encephalopathy, and hepatocellular carcinoma'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'E. Tapper and N. Parikh 2023. "Diagnosis and Management of Cirrhosis
    and Its Complications: A Review." Journal of the American Medical Association
    (JAMA)'
  supporting_citations: []
description: Hepatitis C virus infection is a major etiological factor for cirrhosis,
  accounting for approximately 41% of cirrhosis cases in the US. Chronic HCV infection
  causes progressive liver fibrosis through persistent inflammation and immune-mediated
  hepatocyte injury, ultimately leading to cirrhosis over 20-30 years in untreated
  individuals. The relationship is well-established with significant overlap between
  hepatitis C and other cirrhosis risk factors.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 41.0
    type: prevalence_percentage
    ci_lower: null
    ci_upper: null
  p_value: null
  sample_size: 2200000
moderators:
- name: alcohol_use_disorder
  direction: strengthens
  strength: strong
  description: Co-occurring alcohol use disorder (present in ~45% of cirrhosis cases)
    accelerates progression from hepatitis C to cirrhosis
- name: nonalcoholic_fatty_liver_disease
  direction: strengthens
  strength: moderate
  description: Overlapping NAFLD (present in ~26% of cases) may compound hepatic injury
    and accelerate fibrosis progression
- name: antiviral_treatment
  direction: weakens
  strength: strong
  description: Successful HCV treatment with direct-acting antivirals can halt progression
    and potentially reverse early fibrosis
